BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 1560067)

  • 21. Endothelial cell function and thrombosis.
    Pearson JD
    Baillieres Clin Haematol; 1994 Sep; 7(3):441-52. PubMed ID: 7841594
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of the endothelium in the regulation of the hemostatic system.
    Müller-Berghaus G
    Behring Inst Mitt; 1992 Apr; (91):157-68. PubMed ID: 1524564
    [No Abstract]   [Full Text] [Related]  

  • 23. P-selectin in haemostasis.
    André P
    Br J Haematol; 2004 Aug; 126(3):298-306. PubMed ID: 15257701
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thrombomodulin: a linker of coagulation and fibrinolysis and predictor of risk of arterial thrombosis.
    Wu KK; Matijevic-Aleksic N
    Ann Med; 2000 Dec; 32 Suppl 1():73-7. PubMed ID: 11209986
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Physiopathology of thrombotic microangiopathy].
    Kaminker AJ; Carreras LO
    Sangre (Barc); 1989 Apr; 34(2):130-5. PubMed ID: 2667170
    [No Abstract]   [Full Text] [Related]  

  • 26. Vascular-bed-specific hemostasis and hypercoagulable states: clinical utility of activation peptide assays in predicting thrombotic events in different clinical populations.
    Rosenberg RD
    Thromb Haemost; 2001 Jul; 86(1):41-50. PubMed ID: 11487031
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Blood platelets and the elderly. Relation to the arterial wall and hemostasis].
    Boisseau MR
    Ann Cardiol Angeiol (Paris); 1991 May; 40(5):239-42. PubMed ID: 1859123
    [No Abstract]   [Full Text] [Related]  

  • 28. The role of endothelium in the homeostatic balance of haemostasis.
    Nawroth P; Kisiel W; Stern D
    Clin Haematol; 1985 Jun; 14(2):531-46. PubMed ID: 2994930
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hemostatic changes in vasculitides.
    Trifiletti A; Scamardi R; Bagnato GF; Gaudio A
    Thromb Res; 2009 Jul; 124(3):252-5. PubMed ID: 19525001
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stimulated tissue plasminogen activator release as a marker of endothelial function in humans.
    Oliver JJ; Webb DJ; Newby DE
    Arterioscler Thromb Vasc Biol; 2005 Dec; 25(12):2470-9. PubMed ID: 16210566
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Apoptosis of microvascular endothelial cells in the pathophysiology of thrombotic thrombocytopenic purpura/sporadic hemolytic uremic syndrome.
    Laurence J; Mitra D
    Semin Hematol; 1997 Apr; 34(2):98-105. PubMed ID: 9109211
    [No Abstract]   [Full Text] [Related]  

  • 32. [State of the endothelium and hemostasis in acute leukemia].
    Tarasova LN; Skol'skaia OIu; Vladimirova SG
    Ter Arkh; 2011; 83(7):74-8. PubMed ID: 21894757
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Regulation of the endothelial function by thrombomodulin and/or thrombin receptor].
    Maruyama I; Shigeta K
    Rinsho Ketsueki; 1994 Mar; 35(3):234-7. PubMed ID: 8158841
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pathophysiology and clinical aspects of fibrinolysis and inhibition of coagulation. Experimental and clinical studies with special reference to women on oral contraceptives and selected groups of thrombosis prone patients.
    Jespersen J
    Dan Med Bull; 1988 Feb; 35(1):1-33. PubMed ID: 3277796
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protein C levels in disseminated intravascular coagulation and thrombotic thrombocytopenic purpura: its correlation with other coagulation parameters.
    Takahashi H; Takakuwa E; Yoshino N; Hanano M; Shibata A
    Thromb Haemost; 1985 Aug; 54(2):445-9. PubMed ID: 3841232
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Decreased plasma tissue factor pathway inhibitor levels in patients with thrombotic thrombocytopenic purpura.
    Kobayashi M; Wada H; Wakita Y; Shimura M; Nakase T; Hiyoyama K; Nagaya S; Minami N; Nakano T; Shiku H
    Thromb Haemost; 1995 Jan; 73(1):10-4. PubMed ID: 7740478
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tissue factor in health and disease.
    Semeraro N; Colucci M
    Thromb Haemost; 1997 Jul; 78(1):759-64. PubMed ID: 9198252
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overview of the postulated mechanisms linking cancer and thrombosis.
    ten Cate H; Falanga A
    Pathophysiol Haemost Thromb; 2008; 36(3-4):122-30. PubMed ID: 19176985
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolic control of excessive extracellular nucleotide accumulation by CD39/ecto-nucleotidase-1: implications for ischemic vascular diseases.
    Marcus AJ; Broekman MJ; Drosopoulos JH; Islam N; Pinsky DJ; Sesti C; Levi R
    J Pharmacol Exp Ther; 2003 Apr; 305(1):9-16. PubMed ID: 12649347
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanisms of platelet activation: need for new strategies to protect against platelet-mediated atherothrombosis.
    Jennings LK
    Thromb Haemost; 2009 Aug; 102(2):248-57. PubMed ID: 19652875
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.